Position in JNJ
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$14,460,543
+$602,995 QoQ
Shares Held
56,938
+0.4% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.92%
of 13F equity value
Holder Rank
#909
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Forvis Mazars Wealth Advisors, LLC holds $83,206,945 across 10 Drug Manufacturers - General names. JNJ ranks #2 (17.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
42,430 | $50,891,819 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
56,938 | $14,460,543 | |
| 3 | ABBV |
AbbVie Inc.
|
28,316 | $7,125,438 | |
| 4 | MRK |
Merck & Co., Inc.
|
49,526 | $6,364,091 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
25,031 | $1,442,286 | |
| 6 | PFE |
Pfizer Inc
|
44,567 | $1,073,173 | |
| 7 | AMGN |
Amgen Inc
|
2,240 | $811,148 | |
| 8 | AZN |
Astrazeneca PLC
|
2,202 | $417,543 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14,460,543 | 56,938 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $13,857,548 | 56,691 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $11,708,610 | 56,577 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $10,457,131 | 56,397 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $8,772,127 | 57,428 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $9,727,511 | 58,656 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $6,166,162 | 42,637 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $7,064,519 | 43,592 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $9,262,597 | 63,373 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $8,708,359 | 55,050 | Shares | Sole | 2024-04-19 | |
| 2023-12-31 | $6,702,829 | 42,764 | Shares | Sole | 2024-01-11 | |
| 2023-09-30 | $6,918,726 | 44,422 | Shares | Sole | 2023-10-26 | |
| 2023-06-30 | $7,577,836 | 45,782 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $5,770,340 | 37,228 | Shares | Sole | 2023-04-27 | |
| 2022-12-31 | $6,760,395 | 38,270 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $6,377,574 | 39,040 | Shares | Sole | 2022-10-14 | |
| 2022-06-30 | $6,715,913 | 37,834 | Shares | Sole | 2022-07-22 | |
| 2022-03-31 | $6,260,649 | 35,325 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $5,794,140 | 33,870 | Shares | Sole | 2022-01-14 | |
| 2021-09-30 | $5,535,251 | 34,274 | Shares | Sole | 2021-10-14 | |
| 2021-06-30 | $4,616,509 | 28,023 | Shares | Sole | 2021-07-14 | |
| 2021-03-31 | $5,474,991 | 33,313 | Shares | Sole | 2021-04-23 | |
| 2020-12-31 | $6,350,440 | 40,351 | Shares | Sole | 2021-01-22 | |
| 2020-09-30 | $5,309,507 | 35,663 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $5,198,247 | 36,964 | Shares | Sole | 2020-07-15 | |
| 2020-03-31 | $5,118,003 | 39,030 | Shares | Sole | 2020-04-10 | |
| No filing history on record for this holder in this stock. | ||||||